AXM Pharma, Inc (AXMP)

[Renee]

AXMP SEC Suspension: "The Commission temporarily suspended trading in the securities of AXMP because of questions about the adequacy and accuracy of information concerning AXMP’s leadership and operations contained in a Quarterly Report issued by AXMP on May 14, 2018, AXMP’s press releases issued between July 2, 2018 and July 6, 2018, and a Supplemental Information Report issued by AXMP on July 5, 2018."

https://www.sec.gov/litigation/suspensions/2018/34-83625.pdf

Order:

https://www.sec.gov/litigation/suspensions/2018/34-83625-o.pdf